Novartis - Quaterly Results

A decrease in the sales to Rs. 859.00 millions was observed for the quarter ended December 2025. The sales stood at Rs. 930.00 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 160.90 millions from Rs. 254.50 millions, a decline of -36.78% on QoQ basis.Operating profit for the quarter ended December 2025 decreased to 311.10 millions as compared to 361.80 millions of corresponding quarter ended December 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	859.00	930.00	-7.63	2637.80	2723.90	-3.16	3562.70	3350.70	6.33
Other Income	87.50	106.00	-17.45	287.60	313.30	-8.20	419.60	616.80	-31.97
PBIDT	311.10	361.80	-14.01	1022.40	988.40	3.44	1333.80	1269.40	5.07
Interest	9.80	3.60	172.22	11.90	6.50	83.08	7.70	14.90	-48.32
PBDT	301.30	358.20	-15.88	1010.50	981.90	2.91	1326.10	1254.50	5.71
Depreciation	4.80	5.30	-9.43	15.30	16.60	-7.83	21.90	26.10	-16.09
PBT	296.50	352.90	-15.98	995.20	965.30	3.10	1304.20	1228.40	6.17
TAX	135.60	98.40	37.80	315.90	249.30	26.71	295.20	376.50	-21.59
Deferred Tax	-3.80	0.70	-642.86	-4.30	-11.90	-63.87	-4.40	0.20	-2300.00
PAT	160.90	254.50	-36.78	679.30	716.00	-5.13	1009.00	851.90	18.44
Equity	123.40	123.40	0.00	123.40	123.40	0.00	123.40	123.40	0.00
PBIDTM(%)	36.22	38.90	-6.91	38.76	36.29	6.82	37.44	37.88	-1.18